Two UK growth shares I’m buying

In a hunt for UK growth shares, Christopher Ruane has identified two companies for his portfolio. Here he explains why he’s been buying them.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I am happy collecting dividends from income shares. But I also like the prospect of capital growth. So I’ve been adding UK growth shares to my holdings. Here are two I’m buying for my portfolio.

Proven adman

I was surprised recently to notice that Martin Sorrell had bought 10,000 shares in the company he leads, S4 Capital (LSE: SFOR). After all, he already held over 54m shares in the company. Why buy more?

Like me, he apparently remains excited about the prospects for these UK growth shares. He bought on 17 May during a fallback to £5.13 and the shares have now bounced back to £5.60. Over the past year, the S4 Capital share price has put on 130%.

With his track record at WPP, Sorrell has proven his ability to build an ad agency network at scale. He’s doing the same thing at S4, which now numbers almost 5,000 employees in 31 countries.

UK growth shares

I regard these as growth shares because the company is positioned in digital marketing, which continues to increase in size. With its wide offering and exclusive focus on digital, S4 is positioned to ride this rising tide. That combines with Sorrell’s dealmaking prowess to make S4 capital a growth machine.

The company’s first-quarter results showed revenue up 71%. Even stripping out the impact of acquisitions, like-for-like revenues rose 35%. Reported gross profit also rose 71%, with a like-for-like increase of 33%.

The company is looking to tap the bond markets so it can build a £500m war chest for acquisitions. I continue to see strong growth potential for S4. I would consider buying more of these UK growth shares for my portfolio today.

However, the role of Martin Sorrell here is a risk. While the company’s talent pool is growing fast, it still seems to rely on the vision, energy and skill of its founder. If for any reason he left suddenly, I think it would hurt the S4 Capital share price.

Medical exposure

I recently opened a position in Renalytix AI (LSE: RENX). These UK growth shares made it into my portfolio because, like S4, I think they could be a way to benefit from the increased role of digital technology.

In the case of Renalytix, that’s in the field of kidney diagnosis. Its artificial intelligence platform may allow it to deliver this vital service in a cost-effective way.

Growth potential

I’ve been following Renalytix for a while. But what made me decide to buy these UK growth shares was a combination of two news stories I thought boded well. First came positive results from a clinical study into the use of the company’s flagship product. Then a deal with the US government was announced. It enables Renalytix to supply customers such as the US military.

Such sales are not guaranteed, however. One risk with the Renalytix AI share price is that sales may not materialise fast enough. Competitors are working in the same space. They could impact the revenues it’s able to generate by developing their own cheaper alternatives.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

christopherruane owns shares of S4 Capital plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »

Investing Articles

3 ideas to help investors aim for a million-pound Stocks & Shares ISA

The UK has a growing number of Stocks and Shares ISA millionaires, and this plan may be one of the…

Read more »

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »